↓ Skip to main content

Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Overview of attention for article published in Clinical Drug Investigation, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
4 tweeters

Readers on

mendeley
7 Mendeley
Title
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Published in
Clinical Drug Investigation, July 2019
DOI 10.1007/s40261-019-00826-0
Pubmed ID
Authors

Katherine A. Lyseng-Williamson

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 43%
Student > Master 2 29%
Unspecified 1 14%
Unknown 1 14%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 14%
Unspecified 1 14%
Biochemistry, Genetics and Molecular Biology 1 14%
Nursing and Health Professions 1 14%
Social Sciences 1 14%
Other 1 14%
Unknown 1 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2019.
All research outputs
#7,213,497
of 14,079,291 outputs
Outputs from Clinical Drug Investigation
#384
of 638 outputs
Outputs of similar age
#105,931
of 251,074 outputs
Outputs of similar age from Clinical Drug Investigation
#2
of 7 outputs
Altmetric has tracked 14,079,291 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 638 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,074 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.